Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the 18F-FDG PET/CT Findings.
Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the 18F-FDG PET/CT Findings.
Intern Med. 2017 Sep 25;:
Authors: Takahashi Y, Sato S, Ishitobi H, Nagaoka M, Kobayashi Y, Fukuhara H, Yuki M, Komazawa Y, Kuroda H, Shizuku T
Abstract
Cholangiolocellular carcinoma is a minor primary cancerous tumor of the liver and its coexistence with intrahepatic cholangiocarcinoma in the liver is rare. We herein report a case of concurrent cholangiolocellular carcinoma and intrahepatic cholangiocarcinoma in the liver, in addition to a rectal G1 neuroendocrine tumor, a so-called carcinoid. The intrahepatic tumors showed a different uptake in the 18-fluoro-2-deoxyglucose (FDG) positron-emission tomography (PET)/computed tomography (CT) findings. In addition to conventional dynamic contrast-enhanced CT, we concluded that FDG PET/CT could therefore be a helpful modality to identify the properties of both cholangiolocellular carcinoma and intrahepatic cholangiocarcinoma.
PMID: 28943569 [PubMed - as supplied by publisher]
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
More News: Bile Duct Cancer | Brain | Cancer & Oncology | Carcinoid Tumor | Carcinoma | Cholangiocarcinoma | CT Scan | Hepatocellular Carcinoma | Internal Medicine | Liver | Liver Cancer | Neurology | PET Scan | Urology & Nephrology